Replies to post #203344 on Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

such a nice summary article, and we expect B OM to do much better

[Amatuer17]

Good find - also realistic - not hyperbole

“ Assuming off-label use or extension in other types of cancers and a progressive penetration of the Asian market (around 250.000 HNC patients per year), I believe that global sales of $200 million could be achieved for Validive, of which 50% is taken into account for 2022 sales. “

If they are looking at launching in 2019 and peak sales of $200 million by 2022 - what are predictions for B-OM?
Assuming a 5 time multiplier - it could give $1B for B-OM - not the billions market cap being predicted